This is a pre-solicitation notice for an unrestricted procurement of Dutasteride Capsules for multiple federal agencies, including the VA, DoD, and BOP. The contract will be awarded to one responsible offeror for a one-year base period plus four one-year options, with distribution through Prime Vendor Programs. Offerors must supply the drug under their own unique NDC number and label, and the VA label must securely adhere on top. The required packaging includes 30 and 90 count bottles with specific safety-cap and bottle dimensions. The solicitation is expected to be issued electronically on or about June 22, 2026, with a tentative closing date of July 7, 2026.